PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
11-Jun-2025 Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD Outlook Therapeutics
05-Jun-2025 Elgan Pharma and Chiesi Group Announce First Participating Infants Dosed in Phase 3 Study of ELGN-2112 for Treatment of Intestinal Malabsorption in Preterm Infants Chiesi
03-Jun-2025 Astoriom Expands Global Footprint for Sample Stability Storage Services Astoriom
03-Jun-2025 European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD Takeda
03-Jun-2025 Industry Leading RBQM Event Returns for 2025 CluePoints
03-Jun-2025 Amber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical Trial of VCFix® Spinal System Amber Implants
03-Jun-2025 Biocartis Announces IVDR Class C CDx Certification of the Idylla™ EGFR Mutation Test Biocartis
03-Jun-2025 ASCO: new Sarclisa data support subcutaneous administration with on-body injector Sanofi
02-Jun-2025 Ovation Data Sounds the Alarm in New White Paper - Data Neglect Threatens Lifesciences Sector Ovation Data
29-May-2025 Bionical Emas and Pharma Resources Announce Exclusive Global Clinical Trial Supply Partnership Bionical Emas
28-May-2025 Researchers explore whether a quick, affordable blood test could diagnose neurodegenerative conditions, such as Alzheimer’s disease, at a much earlier stage. UK Dementia Research
27-May-2025 BC Platforms Appoints Senior Product and Marketing Executives to Further Advance Global Expansion and Real-World Data Leadership BC Platforms
21-May-2025 PSI Named a 2025 Fierce CRO Award Finalist for Excellence in Clinical Trial Management PSI CRO
20-May-2025 Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting Santhera
20-May-2025 Eleva Appoints Donato Spota as Chief Financial Officer Eleva
20-May-2025 Brainomix Presents Robust Validation of Its FDA-Cleared e-Lung Technology from its Collaboration with Boehringer Ingelheim Brainomix
20-May-2025 Another Day Pharma announces promising Phase II results for topical post-prostatectomy erectile dysfunction treatment Another Day Pharma Ltd
20-May-2025 Journal of Critical Care publishes positive results from prespecified, biomarker-guided subgroup analysis of AdrenoMed’s Phase II AdrenOSS-2 trial in septic shock AdrenoMed AG
14-May-2025 Southeast Asian stem cell leader Medeze launches voluntary conditional cash partial offer for 10% stake in SGX-listed Cordlife Group Limited Medeze
14-May-2025 Kaerus Bioscience’s lead candidate KER-0193 granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA for treatment of Fragile X syndrome (FXS) Kaerus Bioscience